Thomas Novak, PhD
Chief Scientific Officer, Autobahn Labs
Dr. Tom Novak is the Chief Scientific Officer of Autobahn Labs. Throughout his career, Dr. Novak has held a number of leadership positions at esteemed institutions such as Cellular Dynamics International (CDI), Fate Therapeutics, and Roche Palo Alto.  His work there led to the initiation of three collaborations (CDI, iSTEM, and Harvard Stem Cell Institute) centered around nonclinical safety, neuroscience, and cardiovascular diseases, respectively.

 

Thomas A. Rando, MD, PhD
Professor of Neurology; Director of the UCLA Broad Stem Cell Research Center, UCLA
Dr. Thomas A. Rando is the director of the UCLA Broad Stem Cell Research Center. Dr. Rando and his team study the basic mechanisms of stem cell biology and the biology of aging, to understand how environmental influences affect the aging of stem cells and how alterations of those environmental factors can delay or reverse age-related changes.

 

Pamela Eversole-Cire, PhD
Director of the Biotechnology and CIRM Bridges to Stem Cell Research Programs, Pasadena City College
Dr. Pamela Eversole-Cire is the director of the Biotechnology and CIRM Bridges to Stem Cell Research Programs at Pasadena City College (PCC). She currently holds the position of visiting associate in Biology with the Division of Biology and Biological Engineering at Caltech. Dr. Eversole-Cire’s work has enabled more than 50 students, largely from underprivileged backgrounds, to gain high-quality training and mentorship in the field of stem cell research.

 

Magdalena Zernicka-Goetz, PhD
Bren Professor of Biology and Biological Engineering, Caltech, CA
Dr. Magdalena Zernicka-Goetz is the Bren Professor of Biology and Biological Engineering at Caltech. She pioneered methods through which multiple stem cell types are directed to assemble into complete “synthetic embryos.” Dr. Zernicka-Goetz and her team utilize mouse and stem cell models to study the nuances of embryonic development and cell identity.